[Epidemiology and prevention of hepatitis A].

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Nihon rinsho. Japanese journal of clinical medicine

• Publication date

  2004-08-01

• Fields of study

  Medicine

• Identifiers
  PMID 15453370
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Global Prevalence of Domestic Cat Hepadnavirus: An Emerging Threat to Cats’ Health?

  2022cites this paper
• Hepatitis B among University Population: Prevalence, Associated Risk Factors, Knowledge Assessment, and Treatment Management

  2022cites this paper
• Viral hepatitis in pregnancy

  2022cites this paper
• A Retrospective Evaluation of Patients Hospitalized in the Internal Medicine Department at the Turkey Recep Tayyip Erdogan Somalia Mogadishu Training and Research Hospital

  2021cites this paper
• Chitosan-Based Nanoparticles Against Viral Infections

  2021cites this paper
• A systematic study of Tupaia as a model for human acute hepatitis B infection

  2021cites this paper
• Application of hepatitis B immunoglobulin in prevention of mother-to-child transmission of chronic hepatitis B in HBsAg- and HBeAg-positive mother

  2021cites this paper
• Childhood Immunizations

  2020cites this paper
• Game-Theoretical Model of Retroactive Hepatitis B Vaccination in China

  2020influential citation
• Hepatitis B vaccine development and implementation

  2020cites this paper
• Management of Acute Hepatitis B Virus Infection

  2020cites this paper
• Assessment of knowledge of Senegalese dentists on hepatitis B: A cross-sectional survey

  2019influential citation
• REVIEW ON ROLE OF HERBAL MEDICINES IN LIVER DISORDER

  2019cites this paper
• Serum biomarkers for diagnosis and monitoring viral hepatitis and hepatocellular carcinoma

  2018cites this paper
• The prevalence of hepatitis B and C among blood donors at the National Blood Transfusion Center (CNTS) in Burundi

  2018cites this paper
• TREATMENT OF LIVER DISEASE BY HERBAL DRUGS

  2018cites this paper
• Current Management Strategies in Hepatitis B During Pregnancy

  2017cites this paper
• Low Risk of Hepatitis B Virus Reactivation in HBsAg-negative/Anti-HBc–positive Carriers Receiving Rituximab for Rheumatoid Arthritis: A Retrospective Multicenter Italian Study

  2016cites this paper
• Hepatitis B Leading to Megaloblastic Anemia and Catastrophic Peripheral Thrombocytopenia.

  2016cites this paper
• Reactivation of hepatitis B virus during targeted therapies for cancer and immune-mediated disorders

  2016influential citation
• CD4+ T Cells Are Not Required for Suppression of Hepatitis B Virus Replication in the Liver of Vaccinated Chimpanzees.

  2016cites this paper
• Sero-Prevalence of Bloodborne Tumor Viruses (HCV, HBV, HTLV-I and KSHV Infections) and Related Risk Factors among Prisoners in Razavi Khorasan Province, Iran, in 2008

  2016cites this paper
• Hepatitis A virus

  2016cites this paper
• Identification of occult hepatitis B virus (HBV) infection and viral antigens in healthcare workers who presented low to moderate levels of anti-HBs after HBV vaccination.

  2015cites this paper
• Epidemiological Aspects of Hepatitis B and Prognostic Factors of Cirrhosis in Patients with Chronic Hepatitis B in the Western Amazon

  2015influential citation
• Effects of Dendritic Cells from Hepatitis B Virus Transgenic Mice-Stimulated Autologous Lymphocytes on Hepatitis B Virus Replication: A Study on the Impact of Specific Sensitized Effector Cells on In Vitro Virus Replication

  2015cites this paper
• Hepatitis: Prevalence, Risk Factors and Associated Co-morbidities in LocalPopulation of Karachi, Pakistan

  2015cites this paper
• Some Haematological Parameters of Symptomatic and Asymptomatic Hepatitis B Positive Patients Attending a Nigerian Tertiary Hospital

  2015cites this paper
• Immunogenicity of Hepatitis B Vaccine among Medical Staff of Shahid Madani Hospital of Tabriz, Iran

  2014cites this paper
• Hepatitis B Virus Genotyping Among Chronic Hepatitis B Individuals With Resistance to Lamivudine in Shahrekord, Iran

  2014cites this paper
• Prevalence of Hepatitis B surface Antigen among the Newly Admitted Students of University of Jos, Nigeria

  2014cites this paper
• ایمنی زایی واکسن هپاتیت B در کادر درمانی بیمارستان شهید مدنی تبریز

  2014cites this paper
• Efficacy of lamivudine combined with adefovir dipivoxil versus entecavir monotherapy in patients with hepatitis B‐associated decompensated cirrhosis: A meta‐analysis

  2014cites this paper
• Hepatitis B and hepatitis C viruses: a review of viral genomes, viral induced host immune responses, genotypic distributions and worldwide epidemiology

  2014cites this paper
• High Prevalence of Hepatitis-B Surface Antigen in Pregnant Women Observed in Southwest Nigeria: A Potential Risk for Vertical Hbsag Transmission

  2014cites this paper
• The efficacy of hepatitis B vaccine in Iranian population: A systematic review and meta-analysis

  2014cites this paper
• РОЛЬ ЯДЕРНОГО ФАКТОРА κB У МЕХАНІЗМАХ ПОРУШЕНЬ ОКИСНЮВАЛЬНИХ ПРОЦЕСІВ У СЛИННИХ ЗАЛОЗАХ ЗА УМОВ ВІДТВОРЕННЯ ЕКСПЕРИМЕНТАЛЬНОГО МЕТАБОЛІЧНОГО СИНДРОМУ

  2014cites this paper
• Forty‐eight‐week retrospective study of telbivudine and lamivudine treatment in patients with hepatitis B‐related cirrhosis

  2013cites this paper
• [Characteristics of patients with chronic hepatitis B virus infection. analysis of a series of 474 patients].

  2013cites this paper
• In vitro selection and characterization of single stranded DNA aptamers inhibiting the hepatitis B virus capsid-envelope interaction

  2013cites this paper
• Chronic hepatitis B infection: A global disease requiring global strategies

  2013cites this paper
• Safe Blood Transfusion : Screening for Hepatitis B and Hepatitis C Virus Infections in Potential Blood Donors in Rural Southeast Asia LE VIET

  2013cites this paper
• Genomic Heterogeneity of Hepatitis Viruses (A-E): Role in Clinical Implications and Treatment

  2013influential citation
• HIV Infection and Viral Hepatitis in Drug Abusers

  2013cites this paper
• Evaluation of liver enzymes in asymptomatic chronic hepatitis B virus infected pregnant women

  2013cites this paper
• A bispecific antibody against two different epitopes on hepatitis B surface antigen has potent hepatitis B virus neutralizing activity

  2013influential citation
• Hepatitis B virus hepatotropism is mediated by specific receptor recognition in the liver and not restricted to susceptible hosts

  2013cites this paper
• Productive Hepatitis C Virus Infection of Stem Cell-Derived Hepatocytes Reveals a Critical Transition to Viral Permissiveness during Differentiation

  2012cites this paper
• Non-medical anabolic-androgenic steroid consumption and hepatitis B and C virus infection in regular strength training practitioners

  2012cites this paper
• A Randomized Controlled Trial of Sequential Pegylated Interferon-α and Telbivudine or Vice Versa for 48 Weeks in Hepatitis B E Antigen-Negative Chronic Hepatitis B

  2012cites this paper
• Risk Factors for Liver Disease and Associated Knowledge and Practices Among Mexican Adults in the US and Mexico

  2012cites this paper
• Viral hepatitis: global goals for vaccination.

  2012cites this paper
• Hepatitis B Virus in the United States: Infection, Exposure, and Immunity Rates in a Nationally Representative Survey

  2011cites this paper
• Targeted novel surface-modified nanoparticles for interferon delivery for the treatment of hepatitis B.

  2011cites this paper
• Hepatitis D outbreak among children in a hepatitis B hyper‐endemic settlement in Greenland

  2010cites this paper
• PRINCIPLES OF PREVENTION IN HEPATITIS B INFECTION

  2010cites this paper
• Prevalence of Hepatitis B and C Among Normal Individuals in Tripoli/Libya

  2010cites this paper
• Comparing Knowledge, Health Beliefs, and Self-Efficacy Toward Hepatitis B Prevention Among University Students With Different Hepatitis B Virus Infectious Statuses

  2009cites this paper
• A randomized controlled trial of pegylated interferon-α2a plus adefovir dipivoxil for hepatitis B e antigen-negative chronic hepatitis B

  2009cites this paper
• Entecavir: a step forward in combating hepatitis B disease

  2008cites this paper
• HBV DNA level--the determinant of clinical spectrum and disease outcome in chronic hepatitis B.

  2008cites this paper
• Management of hepatitis B virus.

  2008cites this paper
• Priorities for women's health from the Global Burden of Disease study

  2008cites this paper
• Chronic hepatitis B virus (HBV) infection in pregnancy

  2008cites this paper
• Risk Factors for Chronic Liver Disease in Blacks, Mexican Americans, and Whites in the United States: Results From NHANES IV, 1999–2004

  2008cites this paper
• Influence of epidemiological factors on blood transfusion

  2007cites this paper
• Epidemiology of hepatitis B in the United States

  2007cites this paper
• Improving outcomes for patients with chronic hepatitis B

  2007cites this paper
• Prevalence and associated factors of viral hepatitis and transferrin elevations in 5036 patients admitted to the emergency room of a Swiss university hospital: cross-sectional study

  2007cites this paper
• Trends of Hepatitis A hospitalization and risk factors in Quebec, Canada, between 1990 and 2003

  2007cites this paper
• Impaired dendritic cell function resulting from chronic undernutrition disrupts the antigen-specific immune response in mice.

  2007cites this paper
• Prevention of Food and Waterborne Diseases While Traveling

  2006cites this paper
• Cytotoxic CD4+ T cells in viral hepatitis

  2006cites this paper
• Epidemiología y manifestaciones clínicas de las hepatitis virales

  2006cites this paper
• Efficacy of repeated high‐dose hepatitis B vaccine (80 μg) in patients with chronic liver disease

  2006cites this paper
• Is Hepatitis C Virus Positivity a Contributing Factor to Occult Hepatitis B Virus Infection in Hemodialysis Patients?

  2006cites this paper
• Immunotherapeutic relief from persistent infections and amyloid disorders

  2006cites this paper
• The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide.

  2006cites this paper
• Hepatitis B vaccination in HIV-infected patients: a survey of physicians and patients participating in the Aquitaine cohort.

  2006cites this paper
• Diagnosis of Hepatitis A Virus Infection: a Molecular Approach

  2006cites this paper
• Adherence to universal precautions among laboratory personnel in Lebanon.

  2005cites this paper
• Seguimiento de una cohorte de portadores de virus de la hepatitis B: factores de riesgo para la enfermedad hepática crónica

  2005cites this paper
• Epidemiology and Prevention of Hepatitis B Virus Infection

  2005cites this paper
• "PERSISTENCE OF ANTI-HBs ANTIBODIES IN HEALTHY IRANIAN CHILDREN VACCINATED WITH RECOMBINANT HEPATITIS B VACCINE AND RESPONSE TO A BOOSTER DOSE"

  2005cites this paper
• Integrating Hepatitis B Prevention Into Sexually Transmitted Disease Services: U.S. Sexually Transmitted Disease Program and Clinic Trends—1997 and 2001

  2005cites this paper
• Fully Automated, Internally Controlled Quantification of Hepatitis B Virus DNA by Real-Time PCR by Use of the MagNA Pure LC and LightCycler Instruments

  2004cites this paper
• Occult hepatitis B viral DNA in liver carcinomas from a region with a low prevalence of chronic hepatitis B infection

  2004cites this paper
• Poor validity of self-reported hepatitis B virus infection and vaccination status among young drug users.

  2004cites this paper
• Screening in liver disease: Report of an AASLD clinical workshop

  2004cites this paper
• Viral hepatitis transmission in ambulatory health care settings.

  2004cites this paper
• Bedeutung der Virushepatitis in der Reisemedizin - Erhöhtes Risiko vor allem für Hepatitis A, B und E

  2003cites this paper
• Bedeutung der Virushepatitis in der Reisemedizin - Erhöhtes Risiko vor allem für Hepatitis A, B und E

  2003cites this paper
• Long‐term immunogenicity of an inactivated virosome hepatitis A vaccine

  2002cites this paper